HealthEquity Inc. Earnings Call Highlights Profitable Growth

Healthequity Inc ((HQY)) has held its Q4 earnings call. Read on for the main highlights of the call.

HealthEquity Inc. struck an upbeat tone on its latest earnings call, underscoring powerful operating leverage, sharp margin expansion and record HSA sales that fueled robust cash generation. Management acknowledged early‑stage initiatives and structural underutilization of HSAs as both risk and opportunity, but the call’s message was clear: positive momentum and multiple growth levers outweigh near‑term uncertainties.

Record HSA Sales and Expanding Member Base

HealthEquity delivered record growth in health savings accounts, adding 550,000 HSAs in Q4 and more than 1,000,000 new HSAs from sales over the full year. Total accounts climbed to 17,800,000, reinforcing the company’s position as a leading HSA platform and widening the base for future asset and revenue growth.

HSA Assets Climb with Higher Member Balances

Total HSA assets surpassed $36,000,000,000, rising 14% year over year as asset growth outpaced account expansion. Management highlighted that higher balances per member are driving this divergence, signaling improving member engagement and a richer custodial asset mix that supports long‑term earnings power.

Revenue Growth and Upgraded Top‑Line Outlook

Fourth‑quarter revenue increased 7% year over year to $334.6 million, while fiscal 2026 revenue reached $1,313.0 million, up 9.5%. Confidence in the trajectory led HealthEquity to raise its fiscal 2027 revenue guidance to a range of $1,405 million to $1,415 million, signaling expectations of sustained growth.

Margin Expansion Underpins Profitability Surge

Profitability improved sharply as Q4 adjusted EBITDA jumped 23% to $132.9 million, with margin expanding more than 500 basis points to 40%. For fiscal 2026, adjusted EBITDA reached $566.0 million, a 20% increase, and the full‑year adjusted EBITDA margin rose to an impressive 43%, underscoring strong operating leverage.

Earnings Strength on GAAP and Non‑GAAP Bases

HealthEquity’s bottom line accelerated, with Q4 GAAP net income climbing to $49.7 million, almost doubling year over year. Non‑GAAP net income advanced 33% to $81.8 million, and non‑GAAP diluted EPS rose 38% to $0.95, illustrating broad‑based earnings gains beyond accounting adjustments.

Gross Margin Gains from Efficiency and Lower Service Costs

Gross profit in Q4 reached $228.1 million, and gross margin expanded to 68%, a 700‑basis‑point improvement from 61% a year earlier. Management attributed the margin lift in part to a $17.0 million decline in service costs, driven by lower fraud‑related expenses and ongoing efficiency initiatives.

Security and Fraud Performance Becoming a Competitive Edge

Fraud losses fell to minimal levels, with Q4 fraud reimbursements around $300,000, implying an exit run rate of roughly 0.1 basis points. For the full year, fraud cost dropped to about 1.1 basis points, well below the company’s 1 basis‑point target, reinforcing both risk management discipline and potential cost stability.

Investor Adoption and Digital Engagement on the Rise

The investor cohort within HSAs continued to grow, with HSA investors up 10% year over year and invested assets now exceeding half of total HSA assets. Digital adoption is also gaining traction as mobile app downloads surpassed 3,600,000, supporting automation, engagement and cross‑selling opportunities across the platform.

Capital Returns Backed by Strong Cash Generation

HealthEquity paired growth with shareholder returns, repurchasing more than $300,000,000 of stock in fiscal 2026, including roughly $82 million in Q4, which reduced diluted shares by about 3%. The company generated $457,000,000 in operating cash flow and ended Q4 with $319,000,000 in cash, providing ample flexibility despite ongoing buybacks.

Interest‑Rate Hedging Supports Custodial Yield Visibility

To reduce interest‑rate risk on HSA cash, the company entered forward contracts on U.S. Treasuries with about $2,400,000,000 in notional value at a blended 3.92% rate lock. Q4 annualized yield on HSA cash was 3.57%, and management expects an average yield of roughly 3.8% for fiscal 2027, helping stabilize custodial revenue.

Early Marketplace Launch Targets Health and Wellness Spend

HealthEquity launched a marketplace in Q4 featuring weight‑loss programs, hormone replacement therapy and wearables as new member offerings. Management reported encouraging early adoption and retention metrics, but stressed that marketplace revenues remain small today and are not a material contributor to near‑term forecasts.

Policy Tailwind from ACA Bronze HSA Expansion

A recent legislative change expanded HSA eligibility to certain ACA bronze plan enrollees, effectively enlarging HealthEquity’s addressable market by an estimated 10%. The company has begun to see early inflows from this channel since January and views it as a long‑term distribution and growth opportunity.

Service Revenue Lagging Overall Company Growth

Not all revenue lines are advancing at the same pace, as service revenue in Q4 increased a modest 2% year over year to $127.1 million. This slower expansion in fee‑for‑service activity contrasts with stronger custodial and overall growth, highlighting a mix shift that investors will be watching.

HSA Cash Growth Trails Rapid Investment Expansion

While invested HSA assets surged about 26%, HSA cash balances grew roughly 3%, reflecting members’ increasing preference for investment options. This mix shift boosts long‑term asset potential but could temper custodial revenue growth if cash balances, which earn yield, rise more slowly than investments.

Underutilized HSA Benefits Signal Latent Upside

Management underscored that about 95% of HSA members do not hit contribution limits and more than 90% have yet to invest, spotlighting a sizable engagement gap. While this under‑monetizes the current base, it also represents substantial upside if education, digital tools and incentives can nudge members toward saving and investing.

Marketplace Contribution Still Immature and Uncertain

The company cautioned that its marketplace remains in the early innings, with only a handful of programs currently available and limited revenue today. As a result, management excluded material marketplace contributions from fiscal 2027 guidance, leaving open questions on timing and scale of this potential growth vector.

Interest‑Rate Sensitivity Persists Despite Hedges

Though the $2.4 billion notional in interest‑rate locks moderates near‑term volatility, custodial income remains linked to broader rate trends over time. A prolonged decline in interest rates would gradually pressure yields once hedges roll off or reset, making macro conditions an ongoing watch point.

Leverage and Debt Management Remain in Focus

Net debt stood at about $957,000,000 at quarter‑end, a manageable but meaningful balance as HealthEquity continues repurchases and weighs M&A. Management framed capital allocation as a balance between paying down borrowings and returning cash to shareholders, suggesting leverage will stay a key consideration.

ACA and Retail Channels Bring Growth and Execution Risk

The expansion into ACA bronze and broader retail channels is still nascent, as the law passed after many plan designs were filed. Management noted that conversion patterns and long‑term economics for retail‑acquired members will take time to evaluate, introducing some uncertainty even as the opportunity set widens.

Mobile Adoption Leaves Room for Further Digital Upside

While more than 3.6 million app downloads is a meaningful milestone, it still trails the large eligible user pool cited by analysts. This gap underscores substantial remaining runway for digital engagement, which could drive higher contributions, investment adoption and marketplace participation over time.

Guidance and Forward‑Looking Outlook

HealthEquity lifted its fiscal 2027 guidance, projecting revenue of $1,405 million to $1,415 million and GAAP net income of $239 million to $246 million, translating to EPS of $2.78 to $2.85. The company also targets non‑GAAP net income of $392 million to $400 million, non‑GAAP EPS of $4.56 to $4.65 and adjusted EBITDA of $618 million to $628 million, assumptions that factor in stable HSA yields, ongoing buybacks and solid cash generation.

HealthEquity’s earnings call painted a picture of a company leveraging scale to drive margins, while steadily expanding its HSA footprint and digital reach. Strategic hedging, disciplined security performance and shareholder returns support the bullish narrative, though interest‑rate sensitivity and early‑stage initiatives inject some uncertainty, leaving execution as the next key catalyst for investors to monitor.